Oncotelic's Sapu Nano to Showcase Nanomedicine Platform at BIO-Europe 2026
March 24, 2026 — Oncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnerships for cancer drug development.